No Data
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $310
Wall Street Today: Does Anyone Have the Cash for Stargates
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
DeCODE Genetics: Complete Recombination Map of the Human-genome, a Major Step in Genetics
Live Stock: Stargate Rivals the Scale of the Manhattan Project, Musk Said it's a Pipe Dream
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise